Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events.

Yi X, Zhou Q, Lin J, Chi L.

Int J Stroke. 2013 Oct;8(7):535-9. doi: 10.1111/j.1747-4949.2012.00929.x. Epub 2012 Dec 11.

PMID:
23231453
[PubMed - indexed for MEDLINE]
2.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

PMID:
12512736
[PubMed - indexed for MEDLINE]
Free Article
3.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
[PubMed - indexed for MEDLINE]
4.

Role of antiplatelet drugs in the prevention of cardiovascular events.

Tendera M, Wojakowski W.

Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.

PMID:
14592562
[PubMed - indexed for MEDLINE]
5.

Triflusal for preventing serious vascular events in people at high risk.

Costa J, Ferro JM, Matias-Guiu J, Alvarez-Sabin J, Torres F.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004296. Review.

PMID:
16034926
[PubMed - indexed for MEDLINE]
6.

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.

Kamal AK, Naqvi I, Husain MR, Khealani BA.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008076. doi: 10.1002/14651858.CD008076.pub2. Review.

PMID:
21249700
[PubMed - indexed for MEDLINE]
7.

Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke.

Greer DM.

CNS Drugs. 2010 Dec;24(12):1027-40. doi: 10.2165/11539160-000000000-00000. Review.

PMID:
20932071
[PubMed - indexed for MEDLINE]
8.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
[PubMed - indexed for MEDLINE]
9.

Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.

Hankey GJ, Sudlow CL, Dunbabin DW.

Cochrane Database Syst Rev. 2000;(2):CD001246. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD001246.

PMID:
10796426
[PubMed - indexed for MEDLINE]
10.

From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.

Hacke W.

Cerebrovasc Dis. 2002;13 Suppl 1:22-6. Review.

PMID:
11803184
[PubMed - indexed for MEDLINE]
11.

Antiplatelet resistance in stroke.

Topçuoglu MA, Arsava EM, Ay H.

Expert Rev Neurother. 2011 Feb;11(2):251-63. doi: 10.1586/ern.10.203. Review.

PMID:
21306212
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.

Aronow WS.

Drugs Aging. 1999 Aug;15(2):91-101. Review.

PMID:
10495069
[PubMed - indexed for MEDLINE]
13.

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove EL.

Dan Med J. 2012 Sep;59(9):B4506. Review.

PMID:
22951204
[PubMed - indexed for MEDLINE]
14.

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.

Sudlow CL, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001246. doi: 10.1002/14651858.CD001246.pub2. Review.

PMID:
19821273
[PubMed - indexed for MEDLINE]
16.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

PMID:
21888837
[PubMed - indexed for MEDLINE]
Free Article
17.

Clopidogrel: a review of its use in the prevention of atherothrombosis.

Jarvis B, Simpson K.

Drugs. 2000 Aug;60(2):347-77. Review. Erratum in: Drugs 2001;61(1):52.

PMID:
10983738
[PubMed - indexed for MEDLINE]
18.

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis.

Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR.

BMJ. 2008 Jan 26;336(7637):195-8. doi: 10.1136/bmj.39430.529549.BE. Epub 2008 Jan 17. Review.

PMID:
18202034
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001820. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD001820.

PMID:
16625549
[PubMed - indexed for MEDLINE]
20.

Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis.

Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV.

Arch Intern Med. 2007 Aug 13-27;167(15):1593-9. Review.

PMID:
17698681
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk